Pacer Advisors, Inc. Sangamo Therapeutics, Inc Transaction History

Pacer Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$10.17 - $12.64 $68,688 - $85,370	-6,754 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$10.88 - $17.05 $18,931 - $29,667	-1,740 Reduced 20.49%	6,754 $85,000
Q4 2020 Jan 20, 2021	BUY	$9.23 - $18.18 $5,482 - $10,798	594 Added 7.52%	8,494 $133,000
Q3 2020 Oct 19, 2020	BUY	$9.38 - $12.48 $74,102 - $98,592	7,900 New	7,900 $75,000
Q4 2018 Feb 13, 2019	SELL	$9.51 - $16.6 $156,487 - $273,153	-16,455 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$13.05 - $19.05 $214,737 - $313,467	16,455 New	16,455 $279,000
Q1 2018 May 14, 2018	SELL	$16.7 - $26.35 $30,895 - $48,747	-1,850 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.6 - $17.35 $21,460 - $32,097	1,850	1,850 $30,000

141

60.4M

1.46M

1.84M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $144M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.